Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer - PubMed (original) (raw)
Clinical Trial
. 2005 Nov;11(11):1230-7.
doi: 10.1038/nm1310. Epub 2005 Oct 16.
Edward A Stadtmauer, Nicole Aqui, Ashraf Badros, Julio Cotte, Lisa Chrisley, Elizabeth Veloso, Zhaohui Zheng, Sandra Westphal, Rebecca Mair, Nina Chi, Bashi Ratterree, Mary Francis Pochran, Sabrina Natt, Joanne Hinkle, Cheryl Sickles, Ambika Sohal, Kathleen Ruehle, Christian Lynch, Lei Zhang, David L Porter, Selina Luger, Chuanfa Guo, Hong-Bin Fang, William Blackwelder, Kim Hankey, Dean Mann, Robert Edelman, Carl Frasch, Bruce L Levine, Alan Cross, Carl H June
Affiliations
- PMID: 16227990
- DOI: 10.1038/nm1310
Clinical Trial
Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer
Aaron P Rapoport et al. Nat Med. 2005 Nov.
Abstract
Immunodeficiency is a barrier to successful vaccination in individuals with cancer and chronic infection. We performed a randomized phase 1/2 study in lymphopenic individuals after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for myeloma. Combination immunotherapy consisting of a single early post-transplant infusion of in vivo vaccine-primed and ex vivo costimulated autologous T cells followed by post-transplant booster immunizations improved the severe immunodeficiency associated with high-dose chemotherapy and led to the induction of clinically relevant immunity in adults within a month after transplantation. Immune assays showed accelerated restoration of CD4 T-cell numbers and function. Early T-cell infusions also resulted in significantly improved T-cell proliferation in response to antigens that were not contained in the vaccine, as assessed by responses to staphylococcal enterotoxin B and cytomegalovirus antigens (P < 0.05). In the setting of lymphopenia, combined vaccine therapy and adoptive T-cell transfer fosters the development of enhanced memory T-cell responses.
Comment in
- Vaccinating transplant recipients.
Molldrem JJ. Molldrem JJ. Nat Med. 2005 Nov;11(11):1162-3. doi: 10.1038/nm1105-1162. Nat Med. 2005. PMID: 16270072 No abstract available.
Similar articles
- Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.
Rapoport AP, Aqui NA, Stadtmauer EA, Vogl DT, Fang HB, Cai L, Janofsky S, Chew A, Storek J, Akpek G, Badros A, Yanovich S, Tan MT, Veloso E, Pasetti MF, Cross A, Philip S, Murphy H, Bhagat R, Zheng Z, Milliron T, Cotte J, Cannon A, Levine BL, Vonderheide RH, June CH. Rapoport AP, et al. Blood. 2011 Jan 20;117(3):788-97. doi: 10.1182/blood-2010-08-299396. Epub 2010 Oct 28. Blood. 2011. PMID: 21030558 Free PMC article. Clinical Trial. - Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.
Rapoport AP, Aqui NA, Stadtmauer EA, Vogl DT, Xu YY, Kalos M, Cai L, Fang HB, Weiss BM, Badros A, Yanovich S, Akpek G, Tsao P, Cross A, Mann D, Philip S, Kerr N, Brennan A, Zheng Z, Ruehle K, Milliron T, Strome SE, Salazar AM, Levine BL, June CH. Rapoport AP, et al. Clin Cancer Res. 2014 Mar 1;20(5):1355-65. doi: 10.1158/1078-0432.CCR-13-2817. Epub 2014 Feb 11. Clin Cancer Res. 2014. PMID: 24520093 Free PMC article. Clinical Trial. - Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells.
Rapoport AP, Stadtmauer EA, Aqui N, Vogl D, Chew A, Fang HB, Janofsky S, Yager K, Veloso E, Zheng Z, Milliron T, Westphal S, Cotte J, Huynh H, Cannon A, Yanovich S, Akpek G, Tan M, Virts K, Ruehle K, Harris C, Philip S, Vonderheide RH, Levine BL, June CH. Rapoport AP, et al. Clin Cancer Res. 2009 Jul 1;15(13):4499-507. doi: 10.1158/1078-0432.CCR-09-0418. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509133 Free PMC article. Clinical Trial. - T-cell reconstitution and expansion after hematopoietic stem cell transplantation: 'T' it up!
Porter DL, June CH. Porter DL, et al. Bone Marrow Transplant. 2005 May;35(10):935-42. doi: 10.1038/sj.bmt.1704953. Bone Marrow Transplant. 2005. PMID: 15806121 Review. - Immunity for tumors and microbes after autotransplantation: if you build it, they will (not) come.
Rapoport AP. Rapoport AP. Bone Marrow Transplant. 2006 Feb;37(3):239-47. doi: 10.1038/sj.bmt.1705242. Bone Marrow Transplant. 2006. PMID: 16327812 Review.
Cited by
- Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion.
Brimnes MK, Gang AO, Donia M, Thor Straten P, Svane IM, Hadrup SR. Brimnes MK, et al. Cancer Immunol Immunother. 2012 Aug;61(8):1221-31. doi: 10.1007/s00262-011-1199-8. Epub 2012 Jan 12. Cancer Immunol Immunother. 2012. PMID: 22237888 Free PMC article. - Immunotherapy using dendritic cells against multiple myeloma: how to improve?
Nguyen-Pham TN, Lee YK, Kim HJ, Lee JJ. Nguyen-Pham TN, et al. Clin Dev Immunol. 2012;2012:397648. doi: 10.1155/2012/397648. Epub 2012 Mar 15. Clin Dev Immunol. 2012. PMID: 22481968 Free PMC article. Review. - Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials.
DiGiusto D, Cooper L. DiGiusto D, et al. Cytotherapy. 2007;9(7):613-29. doi: 10.1080/14653240701650320. Cytotherapy. 2007. PMID: 17943498 Free PMC article. Review. - CD8+ T-cell memory in tumor immunology and immunotherapy.
Klebanoff CA, Gattinoni L, Restifo NP. Klebanoff CA, et al. Immunol Rev. 2006 Jun;211:214-24. doi: 10.1111/j.0105-2896.2006.00391.x. Immunol Rev. 2006. PMID: 16824130 Free PMC article. Review. - Toward the development of true "off-the-shelf" synthetic T-cell immunotherapy.
Iriguchi S, Kaneko S. Iriguchi S, et al. Cancer Sci. 2019 Jan;110(1):16-22. doi: 10.1111/cas.13892. Epub 2019 Jan 1. Cancer Sci. 2019. PMID: 30485606 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials